Healthtech Startups

Muse is a brain-sensing wearable platform that combines EEG and fNIRS technology to help users improve sleep, manage stress, and enhance cognitive performance through real-time neurofeedback. The company serves consumers seeking measurable mental health and brain training tools backed by clinical research.

5 investors

Nabla provides an AI assistant for clinical documentation and workflows, used by healthcare organizations and clinicians. It is deployed across more than 150 health organizations.

5 investors

Naborforce connects older adults and their families to a vetted network of community members (Nabors) who provide caregiving support, companionship, and assistance. The platform addresses the needs of seniors and their families through technology-enabled neighborhood connections.

5 investors

Nanochon develops Chondrograft, a 3D-printed, off-the-shelf orthopedic implant that is press-fit into damaged knee cartilage to support the body's natural tissue healing. It targets "pre-replacement" patients with focal cartilage defects who need more than temporary relief but are not yet candidates for joint replacement.

5 investors

NeoDocs provides at-home health assessment tests with lab-quality accuracy and personalized health monitoring for consumers seeking preventive wellness. The company focuses on proactive health optimization rather than disease treatment.

5 investors

NEOH is a food-tech company that produces confectionery without sugar or sugar-like substitutes while maintaining taste. The company targets the global candy market with a focus on healthier, conscious consumption.

5 investors

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.

5 investors

Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.

5 investors

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients. The company focuses on advancing neuromodulation technology to provide durable symptom relief and improve respiratory health outcomes.

5 investors

Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders. It focuses on science-driven drug development to address GI conditions that affect patients' quality of life.

5 investors

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system. Founded by neuroscientists and stem cell researchers from UC San Francisco, it operates a regenerative medicine discovery platform and manufactures neuronal, glial, and gene-edited cell therapy candidates in its own cGMP facility.

5 investors

NeuroNav provides person-centered planning and independent facilitation services to help individuals with developmental disabilities navigate and utilize self-determination services in California's regional centers. The company uses research-backed approaches to match clients with appropriate support options and services tailored to their life goals.

5 investors

New Lantern builds software for radiologists that consolidates workflow across multiple systems—worklist management, image viewing, and reporting—to reduce administrative overhead and let radiologists focus on reading studies and making diagnoses. The platform includes an AI assistant called Curie that learns individual radiologist reporting styles to draft reports automatically.

5 investors

Nicolette develops technology to improve interactions between patients and healthcare providers, with a focus on better outcomes, patient experience, care team experience, and cost reduction in healthcare delivery.

5 investors

Nilo Saúde provides AI agents and automation solutions designed for healthcare institutions to improve operational efficiency and financial outcomes. The platform offers AI-powered assistance for patient management, scheduling, data collection, and administrative tasks, built specifically for healthcare professionals.

5 investors

Nimble provides digital workflow and patient engagement software for independent and regional pharmacies, helping them manage prescription fulfillment, mobile checkout, and patient communications. The platform improves medication adherence and enables life sciences companies to access commercial intelligence on therapy adoption.

5 investors

Noah Labs develops AI-powered algorithms and telemonitoring software for early detection of cardiac decompensation and heart failure management in clinical settings. The company's technology integrates external medical devices and algorithms to enable remote patient monitoring for healthcare providers.

5 investors

Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy. The company serves interventional pulmonologists and patients requiring respiratory diagnostic procedures.

5 investors

Nodal operates a platform connecting surrogates (gestational carriers) and intended parents, with tools and education to support both parties through the surrogacy process. It combines technology with a team of clinicians, nurses, and former surrogates to make surrogacy more accessible and transparent.

5 investors

Nomi Health provides direct healthcare services and streamlines payment, claims, and contracts to reduce costs. The company serves patients and healthcare providers in the United States by eliminating healthcare system intermediaries.

5 investors

Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.

5 investors

NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH. Its programs target patient populations with limited existing treatment options.

5 investors

Nostos Genomics develops genetic testing interpretation tools to improve the accuracy, speed, and accessibility of variant analysis for patients with rare and genetic diseases. The company addresses the diagnostic bottleneck in genetic sequencing by providing better information interpretation for patients and healthcare systems.

5 investors

Noze develops a breath-analysis platform that uses nano-sensor "smell on silicon" chips and AI neural models to detect trace molecular patterns in exhaled breath and translate them into diagnostic signals. The device, aimed at clinical diagnostics and point-of-care use, is still under development and not yet cleared for commercial sale.

5 investors